Concentra Biosciences to acquire iTeos Therapeutics for $10.047 per share Jul 21, 2025 07:30AM
iTeos Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $10.047 in Cash per Share Plus a Contingent Value Right Jul 21, 2025 07:29AM
iTeos Therapeutics (ITOS) GALAXIES Lung-201 of Belrestotug + Dostarlimab did not meet established criteria for clinically meaningful improvements in progression free survival May 13, 2025 07:56AM
iTeos Reports Topline Interim Results from GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients May 13, 2025 07:55AM
iTeos to Participate in Upcoming Investor Conferences Mar 1, 2024 07:00AM


Feb 28, 2023 07:00AM iTeos to Present at Cowen 43rd Annual Health Care Conference
Feb 28, 2023 07:00AM iTeos to Present at Cowen 43rd Annual Health Care Conference
Mar 1, 2022 07:00AM iTeos to Present at the Cowen 42nd Annual Health Care Conference
Mar 1, 2022 07:00AM iTeos to Present at the Cowen 42nd Annual Health Care Conference
Feb 23, 2021 07:00AM iTeos to Present at Upcoming Investor Conferences in March
Feb 23, 2021 07:00AM iTeos to Present at Upcoming Investor Conferences in March